Activation of nuclear factor-kappaB is necessary for myotrophin-induced cardiac hypertrophy.
about
miR-375 enhances palmitate-induced lipoapoptosis in insulin-secreting NIT-1 cells by repressing myotrophin (V1) protein expressionCapping protein regulators fine-tune actin assembly dynamicsKinetic mRNA Profiling in a Rat Model of Left-Ventricular Hypertrophy Reveals Early Expression of Chemokines and Their ReceptorsFAK-related nonkinase attenuates hypertrophy induced by angiotensin-II in cultured neonatal rat cardiac myocytesNuclear factor-kappaB activation leads to down-regulation of fatty acid oxidation during cardiac hypertrophyNuclear co-translocation of myotrophin and p65 stimulates myocyte growth. Regulation by myotrophin hairpin loopsLosartan reduced connexin43 expression in left ventricular myocardium of spontaneously hypertensive ratsAnalysis of p53 and NF-κB signaling in modulating the cardiomyocyte fate during hypertrophySignificance of thymosin β4 and implication of PINCH-1-ILK-α-parvin (PIP) complex in human dilated cardiomyopathyInfluence of p53 in the transition of myotrophin-induced cardiac hypertrophy to heart failureThymosin beta 4 prevents oxidative stress by targeting antioxidant and anti-apoptotic genes in cardiac fibroblastsFunction of microRNA-375 and microRNA-124a in pancreas and brain.miR-301a as an NF-κB activator in pancreatic cancer cells.Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesisPrevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors.Re-employment of developmental transcription factors in adult heart diseaseExogenous H2S contributes to recovery of ischemic post-conditioning-induced cardioprotection by decrease of ROS level via down-regulation of NF-κB and JAK2-STAT3 pathways in the aging cardiomyocytes.Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaB.Gambogic acid moderates cardiac responses to chronic hypoxia likely by acting on the proteasome and NF-κB pathway.Ca2+/calmodulin-dependent kinase II triggers cell membrane injury by inducing complement factor B gene expression in the mouse heartBlockade of NF-kappaB using IkappaB alpha dominant-negative mice ameliorates cardiac hypertrophy in myotrophin-overexpressed transgenic mice.The potential of soluble epoxide hydrolase inhibition in the treatment of cardiac hypertrophyQuantitative phosphoproteomic study of pressure-overloaded mouse heart reveals dynamin-related protein 1 as a modulator of cardiac hypertrophySilencing the myotrophin gene by RNA interference leads to the regression of cardiac hypertrophy.V-1 regulates capping protein activity in vivo.Inhibition of DNA methylation reverses norepinephrine-induced cardiac hypertrophy in rats.Anchoring skeletal muscle development and disease: the role of ankyrin repeat domain containing proteins in muscle physiology.Targeting PPARβ/δ for the treatment of type 2 diabetes mellitus.Angiotensin II down-regulates natriuretic peptide receptor-A expression and guanylyl cyclase activity in H9c2 (2-1) cardiac myoblast cells: Role of ROS and NF-κB.S100A8/MYD88/NF-қB: a novel pathway involved in cardiomyocyte hypertrophy driven by thyroid hormone.Surgical optimization and characterization of a minimally invasive aortic banding procedure to induce cardiac hypertrophy in mice.NF-κB mediated miR-21 regulation in cardiomyocytes apoptosis under oxidative stress.Sang-qi Granula Reduces Blood Pressure and Myocardial Fibrosis by Suppressing Inflammatory Responses Associated with the Peroxisome Proliferator-Activated Receptors and Nuclear Factor κ B Protein in Spontaneously Hypertensive Rats.Thymosin beta 4 protects cardiomyocytes from oxidative stress by targeting anti-oxidative enzymes and anti-apoptotic genes.Cardiac-specific blockade of NF-kappaB in cardiac pathophysiology: differences between acute and chronic stimuli in vivo.Inhibition of NF-kappaB induces regression of cardiac hypertrophy, independent of blood pressure control, in spontaneously hypertensive rats.NF-κB mediated miR-26a regulation in cardiac fibrosis.Suppression of atrial natriuretic peptide/natriuretic peptide receptor-A-mediated signaling upregulates angiotensin-II-induced collagen synthesis in adult cardiac fibroblasts.Relief from a heavy heart: redox-sensitive NF-kappaB as a therapeutic target in managing cardiac hypertrophy.MicroRNAs: 'ribo-regulators' of glucose homeostasis.
P2860
Q24630175-71B2F8E5-79DC-45B5-BF87-185CBC7EE1B4Q27006034-F60E0C5D-1139-45EC-8700-FFB3617CF0FBQ27326691-0CD69E6F-CC74-49A8-94BE-EBCA7F6AE036Q28566827-C2FB26CB-F4A2-4291-A299-38F26A141FA9Q28570494-4C70F4F1-551C-4D6F-B34A-F8B610750847Q28580293-77A9DA00-A240-4612-AA57-9081A54AE7E1Q28582203-6E9A03ED-BE75-49B1-AB39-3A1D3D46992BQ28583532-B0161D34-F594-4284-92D4-8B6B0F24CE2BQ33916456-6A8FBA9D-2CF0-4857-BF1E-89B523B5176EQ33997650-D3131846-9C40-4C05-9C15-1A101C95A5F0Q34064815-442CC9A4-D48B-447E-A9C8-008A0C737FFDQ34094840-ADAE668D-D90D-4148-802E-AB9C0D4E904DQ34485753-E82451E0-0345-4DE9-B5E3-7BB44E4C856FQ35147895-BE303144-F336-4880-99B1-9E72063EA0F7Q35214761-4A4C6DD0-069D-4662-9737-0D0F0BA0BFB6Q35757916-FB669640-7051-4FF4-A55E-E2AC948F50FFQ35994514-66B38533-1DAA-47D2-B96E-234F48D07BDFQ36514490-7E43D4BD-35D2-4CB6-A5DC-52ECD5F84CCEQ37116324-931E486E-1153-4569-8A06-2AEF62FAAB99Q37143342-46DA23D1-B38A-4567-845B-31666058FF28Q37208204-36DFD849-0FBA-45A8-AB15-51418DEB38CCQ37264079-2FC216B3-0C48-4FDC-8C11-84CAC4F45889Q37289370-C264FAE9-5649-4AA1-BCB2-4E2E82CD5C9CQ37298305-380F7B55-903C-46B8-936E-117BA9394FBCQ37379868-D29CB5D7-D97E-4612-89CD-0D641E81D06BQ37591215-D0DDC263-D596-486C-B823-1A0D0CEA145CQ37761923-FE40929A-E34B-425B-BCDB-E8618B233569Q37978926-F9FD4AF7-5D58-4214-8BB2-F57DB52813CAQ38848847-E14E27DC-AB28-435C-BB5E-12A1949A1EB9Q38978641-4D7574D1-1E56-402B-BA30-C8B624CD528EQ39636764-6706F7BE-6927-47A1-B91F-6EAE5D4007DBQ41166567-2AD8E2AD-2416-4099-B732-9EAC5EFA68F9Q42141141-B8B3DAAA-DB1F-492A-B42D-ADEA42622F8FQ42261788-B6CBA81A-8128-4616-90C1-59A09AED6915Q45253902-97A5BA7F-1765-4CBA-B48D-47477D9AB4C4Q45304598-1758ADCF-4CB1-41D1-B50D-6CE8698FC566Q46054688-FC84557D-0382-44EE-9851-2CE818AE7AC0Q46322063-52BD5649-452B-4459-AFBA-66A3D9069CDEQ46551309-7DDDB26C-ADB7-45B6-8DAE-F17112669831Q46883052-AE270759-6071-4F27-B352-712D016D79A2
P2860
Activation of nuclear factor-kappaB is necessary for myotrophin-induced cardiac hypertrophy.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Activation of nuclear factor-k ...... n-induced cardiac hypertrophy.
@ast
Activation of nuclear factor-k ...... n-induced cardiac hypertrophy.
@en
type
label
Activation of nuclear factor-k ...... n-induced cardiac hypertrophy.
@ast
Activation of nuclear factor-k ...... n-induced cardiac hypertrophy.
@en
prefLabel
Activation of nuclear factor-k ...... n-induced cardiac hypertrophy.
@ast
Activation of nuclear factor-k ...... n-induced cardiac hypertrophy.
@en
P2093
P2860
P356
P1476
Activation of nuclear factor-k ...... n-induced cardiac hypertrophy.
@en
P2093
Anning Lin
Nicole H Purcell
Sudhiranjan Gupta
P2860
P304
P356
10.1083/JCB.200207149
P407
P577
2002-12-16T00:00:00Z